T37.1X

Clinical Causes: Incorrect or excessive use of antimycobacterial medications Sensitivity or allergic reactions to the drugs Drug interactions leading to increased toxicity Poor adherence to prescribed treatment, leading to underdosing or skipping doses Pharmacogenetic factors affecting drug metabolism Accidental ingestion of medications Use of counterfeit or non-standard medications

Key Symptoms: Gastrointestinal issues such as nausea, vomiting, diarrhea Neurological symptoms including headache, dizziness, or tremors Signs of liver damage like jaundice or dark urine Skin reactions such as rash or itching Respiratory difficulties or chest discomfort Muscle weakness or joint pain Fever or chills Signs of toxicity such as confusion or seizures in severe cases

Diagnosis Path: Diagnosis often involves a thorough review of the patient's medical history, medication usage, and symptom presentation. Laboratory tests, including liver function tests and blood work, may help identify drug toxicity. Blood concentrations of specific antimycobacterial agents can be measured to confirm exposure levels. Healthcare providers might also evaluate for potential allergic reactions or drug interactions. Precise identification of the causative agent and monitoring for adverse effects are essential steps for appropriate management.

Treatment Protocols: Management typically involves immediate discontinuation of the suspected offending agent in cases of poisoning or adverse effects. Supportive care includes hydration, symptom relief, and monitoring vital signs. In severe cases, specific treatments such as chelation therapy or hospitalization might be necessary. Clinicians may also adjust medication dosages, switch to alternative drugs, or implement gradual reintroduction protocols under close supervision. Prevention strategies include patient education on medication adherence, awareness of side effects, and regular follow-up during therapy.